RxDoctor Payments Data

Stefan Brecke, PA

Physician Assistant · Suffolk, VANPI 1457318040

Payments from drug & device makers

$8,592in general payments, 2019–2025

Across 476 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$821
  • GSK$731
  • Boehringer Ingelheim$621
  • Pfizer$593
  • Baxter Healthcare$523
  • plus $4K from 46 others

What the payments were for

  • Food & beverage$8,592100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,592 in reported general payments places this provider in the 95th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$196,777
Medicare patients
629
Services billed
2,638

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban50$54,459
XareltoRivaroxaban39$38,324
JanuviaSitagliptin Phosphate36$37,178
JardianceEmpagliflozin23$28,538
TrulicityDulaglutide12$18,289
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$17,394
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$4,630
Atorvastatin Calcium611$4,398
NorvascAmlodipine Besylate12$4,127
Rosuvastatin Calcium280$3,898
PaxlovidNirmatrelvir/Ritonavir30$2,793
Amlodipine Besylate635$2,777
Albuterol Sulfate HfaAlbuterol Sulfate99$2,570
Omeprazole240$2,501
Telmisartan-HydrochlorothiazidTelmisartan/Hydrochlorothiazid21$2,480

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$593$57,25380 claims
Johnson & JohnsonXarelto$145$38,32439 claims
MerckJanuvia$196$37,17836 claims
Boehringer IngelheimJardiance$621$28,53823 claims
Lilly USA, LLCTrulicity$286$18,28912 claims
GSKTrelegy Ellipta$731$17,39427 claims
AbbVieSynthroid$821$74829 claims
Almatica Pharma LLCSertraline Hcl$64$54683 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Suffolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →